𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Methylation profile of circulating plasma DNA in patients with pancreatic cancer

✍ Scribed by Anatoliy A. Melnikov; Denise Scholtens; Mark S. Talamonti; David J. Bentrem; Victor V. Levenson

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
70 KB
Volume
99
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Detection of free-circulating tumor-asso
Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis
✍ Thierry Lecomte; Anne Berger; Franck ZinzindohouΓ©; StΓ©phanie Micard; Bruno Landi πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 146 KB πŸ‘ 1 views

## Abstract Tumor cells are characterized by specific genetic alterations. When such genetic alterations are identified in body fluid including plasma, regardless of the presence of detectable tumor cells, it shows the existence of free‐circulating tumor‐associated DNA. The objective of our study w

TP53 gene mutations in plasma DNA of can
TP53 gene mutations in plasma DNA of cancer patients
✍ Jose M. Silva; Rocio Gonzalez; Gemma Dominguez; Jose M. Garcia; Pilar EspaΓ±a; Fe πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

Using different molecular techniques, DNA has been shown to be present in plasma of patients with several types of tumors. Mutations of TP53 are the most common genetic changes in human cancers. We investigated the presence of TP53 gene mutations in plasma DNA of breast and small cell lung cancer pa

DNA cytosine methylation in brain of pat
DNA cytosine methylation in brain of patients with Alzheimer's disease
✍ Netanel G. Schwob; Josephine Nalbantoglu; Kenneth E. M. Hastings; Tom Mikkelsen; πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 399 KB πŸ‘ 2 views

## Abstract We developed a novel quantitative assay to test the hypothesis that defects in DNA cytosine methylation might be responsible for the brain chromatin abnormalities and transcriptional alterations observed in patients with Alzheimer's disease (AD). We found no significant difference in pe